Nuveen Asset Management, LLC Neoleukin Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.25 $120,201 - $293,971	-130,654 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.72 - $5.23 $2,543 - $7,735	1,479 Added 1.14%	130,654 $252,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.75 $50,847 - $84,746	-10,935 Reduced 7.8%	129,175 $614,000
Q3 2021 Nov 12, 2021	SELL	$6.05 - $9.66 $3,932 - $6,279	-650 Reduced 0.46%	140,110 $1.16 Million
Q2 2021 Aug 16, 2021	SELL	$9.23 - $13.12 $10,346 - $14,707	-1,121 Reduced 0.79%	140,760 $1.3 Million
Q1 2021 May 17, 2021	SELL	$11.26 - $15.78 $1.79 Million - $2.51 Million	-158,965 Reduced 52.84%	141,881 $1.75 Million
Q4 2020 Feb 16, 2021	SELL	$10.17 - $14.56 $54,572 - $78,128	-5,366 Reduced 1.75%	300,846 $4.24 Million
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $947,836 - $1.67 Million	97,917 Added 47.01%	306,212 $3.68 Million
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $2.07 Million - $3.55 Million	208,295 New	208,295 $3.46 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.